Gelteq Limited - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
GELS Nasdaq 2830 www.gelteq.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Gelteq Limited

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - May 20th, 2026 6:00 am
Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA - May 14th, 2026 6:35 am
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - May 12th, 2026 6:00 am
Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million - Apr 2nd, 2026 4:55 am
Q1 Virtual Investor Summit Presentations Now Available On Demand - Mar 26th, 2026 1:46 pm
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26) - Mar 20th, 2026 6:00 am
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership - Feb 11th, 2026 6:45 am
Gelteq announces preclinical results on medicinal cannabinoid absorption - Jan 14th, 2026 7:16 am
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform - Jan 13th, 2026 7:00 am
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program - Dec 16th, 2025 7:05 am
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China - Dec 9th, 2025 7:15 am
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform - Dec 5th, 2025 8:30 am
Gelteq to Present at Investor Summit Virtual on December 9, 2025 - Dec 2nd, 2025 6:30 am
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform - Nov 24th, 2025 6:30 am
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform - Oct 23rd, 2025 7:00 am
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - Oct 9th, 2025 6:00 am
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - Sep 12th, 2025 5:30 am
Top Midday Gainers - Sep 5th, 2025 11:46 am
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market - Sep 5th, 2025 9:26 am
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs - Sep 4th, 2025 6:35 am